Biomaterials for Improving Skin Penetration in Treatment of Skin Cancer
Source abstract
Abstract
Skin cancer is among the most common malignancies worldwide, posing a significant societal burden due to its increasing incidence and its limited responsiveness to conventional topical therapies. Treatment is challenged by the presence of the skin barrier which restricts drug penetration. This review discusses the structural and physiological challenges of topical delivery and summarizes efforts to develop functional biomaterials to enhance skin drug penetration. Important aspects to consider when developing formulation strategies, such as drug properties and release mechanisms, are discussed alongside current limitations and future perspectives.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Wound Healing and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Heath Technology, Technical University of Denmark, DK-2800 Lyngby, Denmark
Department of Chemistry, Technical University of Denmark, DK-2800 Lyngby, Denmark
Funding
DTU Health Tech
References (100+)
Show source-provided references
1. Global, Regional, and National Trends in the Burden of Melanoma and Non-Melanoma Skin Cancer: Insights from the Global Burden of Disease Study 1990–202110.1038/s41598-025-90485-3 ↗
2. Overview of Skin Cancer Types and Prevalence Rates across Continents10.1016/j.cpt.2024.08.002 ↗
3. Global Burden of Cutaneous Melanoma in 2020 and Projections to 204010.1001/jamadermatol.2022.0160 ↗
4. The Journey from Melanocytes to Melanoma10.1038/s41568-023-00565-7 ↗
5. Diagnosis and Management of Skin Cancer10.1016/j.mpmed.2021.04.007 ↗
6. Dermatologist-Level Classification of Skin Cancer with Deep Neural Networks10.1038/nature21056 ↗
7. Melanoma10.1016/S0140-6736(18)31559-9 ↗
8. Combined Immune Checkpoint Blockade (Anti-PD-1/Anti-CTLA-4): Evaluation and Management of Adverse Drug Reactions10.1016/j.ctrv.2017.05.003 ↗
9. De-Novo and Acquired Resistance to Immune Checkpoint Targeting10.1016/S1470-2045(17)30607-1 ↗
10. Topical Treatments for Skin Cancer10.1016/j.addr.2019.11.002 ↗
11. Stratum Corneum Defensive Functions: An Integrated View
12. Carriers in the Topical Treatment of Skin Disease10.1007/978-3-642-00477-3_15 ↗
13. Gupta, N., Gupta, G.D., and Singh, D. (2022). Localized Topical Drug Delivery Systems for Skin Cancer: Current Approaches and Future Prospects. Front. Nanotechnol., 4.10.3389/fnano.2022.1006628 ↗
14. Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future10.1124/pharmrev.123.000549 ↗
15. Skin Biology10.1038/445833a ↗
16. Basic Physiology of the Skin
17. Barrier Function of the Skin: “La Raison d’Être” of the Epidermis10.1046/j.1523-1747.2003.12359.x ↗
18. Structure and Function of the Epidermal Barrier10.1016/j.ajic.2006.05.295 ↗
19. Basement Membranes in Skin: Unique Matrix Structures with Diverse Functions?10.1007/s00418-009-0586-0 ↗
20. The Skin: An Indispensable Barrier10.1111/j.1600-0625.2008.00786.x ↗
21. Mosca, S., Ottaviani, M., Briganti, S., Di Nardo, A., and Flori, E. (2025). The Sebaceous Gland: A Key Player in the Balance Between Homeostasis and Inflammatory Skin Diseases. Cells, 14.10.3390/cells14100747 ↗
22. Aging and Homeostasis of the Hypodermis in the Age-Related Deterioration of Skin Function10.1038/s41419-024-06818-z ↗
23. Migration of Epidermal Keratinocytes: Mechanisms, Regulation, and Biological Significance10.1007/s00709-003-0031-5 ↗
24. Corneocytes: Relationship between Structural and Biomechanical Properties10.1159/000513054 ↗
25. Melanin Transfer and Fate within Keratinocytes in Human Skin Pigmentation10.1093/icb/icab094 ↗
26. Cioce, A., Cavani, A., Cattani, C., and Scopelliti, F. (2024). Role of the Skin Immune System in Wound Healing. Cells, 13.10.3390/cells13070624 ↗
27. Skin, the Final Frontier10.1016/S0378-5173(01)00731-1 ↗
28. Current Status and Future Potential of Transdermal Drug Delivery10.1038/nrd1304 ↗
29. Functional Nano-Systems for Transdermal Drug Delivery and Skin Therapy10.1039/D2NA00530A ↗
30. Nanotechnology and the Transdermal Route: A State of the Art Review and Critical Appraisal10.1016/j.jconrel.2009.10.016 ↗
31. Transdermal Drug Delivery10.1038/nbt.1504 ↗
32. Role of Skin Enzymes in Metabolism of Topical Drugs10.20517/mtod.2024.17 ↗
33. The PH of the Skin Surface and Its Impact on the Barrier Function10.1159/000094670 ↗
34. The 500 Dalton Rule for the Skin Penetration of Chemical Compounds and Drugs10.1034/j.1600-0625.2000.009003165.x ↗
35. Yu, Y.Q., Yang, X., Wu, X.F., and Fan, Y. (2021). Bin Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.646554 ↗
36. An Update of Skin Permeability Data Based on a Systematic Review of Recent Research10.1038/s41597-024-03026-4 ↗
37. Predicting Skin Permeability
38. Chen, C.P., Chen, C.C., Huang, C.W., and Chang, Y.C. (2018). Evaluating Molecular Properties Involved in Transport of Small Molecules in Stratum Corneum: A Quantitative Structure-Activity Relationship for Skin Permeability. Molecules, 23.10.3390/molecules23040911 ↗
39. Simulating the Skin Permeation Process of Ionizable Molecules10.1021/acs.jcim.4c00722 ↗
40. Quantitative Prediction of Ionization Effect on Human Skin Permeability10.1016/j.ijpharm.2017.03.009 ↗
41. Predicting Skin Permeability by Means of Computational Approaches: Reliability and Caveats in Pharmaceutical Studies10.1021/acs.jcim.8b00934 ↗
42. Recent Progress in Topical and Transdermal Approaches for Melanoma Treatment10.1007/s13346-024-01738-z ↗
43. Nanoparticles for Topical Drug Delivery: Potential for Skin Cancer Treatment10.1016/j.addr.2020.05.011 ↗
44. Recent Advances in Lipid-Based Nanocarriers for Advanced Skin Cancer Therapy10.1016/j.ijpharm.2025.125203 ↗
45. Engineering Precision Nanoparticles for Drug Delivery10.1038/s41573-020-0090-8 ↗
46. Skin Cancer Biology and Barriers to Treatment: Recent Applications of Polymeric Micro/Nanostructures10.1016/j.jare.2021.06.014 ↗
47. Nanoparticles and Microparticles for Skin Drug Delivery10.1016/j.addr.2011.01.012 ↗
48. Topical Nanoparticles for the Treatment of Skin Cancer: Present Concerns and Challenges10.1016/j.jddst.2025.107566 ↗
49. Current Updated Review on Preparation of Polymeric Nanoparticles for Drug Delivery and Biomedical Applications10.1016/j.nxnano.2023.100013 ↗
50. Skin Cancer Therapeutics: Nano-Drug Delivery Vectors—Present and Beyond10.1186/s43094-021-00326-z ↗
51. Drug Delivery Nanoparticles in Skin Cancers10.1155/2014/895986 ↗
52. Nanoparticles as a Therapeutic Delivery System for Skin Cancer Prevention and Treatment10.1016/j.xjidi.2023.100197 ↗
53. Overview of Dendrimers as Promising Drug Delivery Systems with Insight into Anticancer and Anti-Microbial Applications
54. On the Formation and Stability Mechanisms of Diverse Lipid-Based Nanostructures for Drug Delivery10.1016/j.cis.2025.103402 ↗
55. Structure-Centered Design of Lipid-Based Nanocarriers to Overcome Biological Barriers10.1016/j.mtbio.2025.102425 ↗
56. Giordano, A., Provenza, A.C., Reverchon, G., Baldino, L., and Reverchon, E. (2024). Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy. Pharmaceutics, 16.10.3390/pharmaceutics16091158 ↗
57. García-Pinel, B., Porras-Alcalá, C., Ortega-Rodríguez, A., Sarabia, F., Prados, J., Melguizo, C., and López-Romero, J.M. (2019). Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment. Nanomaterials, 9.10.3390/nano9040638 ↗
58. Nanoemulsion: A Pharmaceutical Review10.4103/0975-8453.59509 ↗
59. Chatzidaki, M.D., and Mitsou, E. (2025). Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes. Pharmaceutics, 17.10.3390/pharmaceutics17030337 ↗
60. Preparation and Therapeutic Implications of Essential Oil-Based Nanoemulsions: A Review10.1016/j.colsurfb.2025.114939 ↗
61. Nanoemulsion: Concepts, Development and Applications in Drug Delivery10.1016/j.jconrel.2017.03.008 ↗
62. Nanoemulsions versus Microemulsions: Terminology, Differences, and Similarities10.1039/C2SM06903B ↗
63. Lu, G.W., and Gao, P. (2010). Emulsions and Microemulsions for Topical and Transdermal Drug Delivery. Handbook of Non-Invasive Drug Delivery Systems, William Andrew Publishing.10.1016/B978-0-8155-2025-2.10003-4 ↗
64. Topical Delivery of Nanoemulsions for Skin Cancer Treatment10.1016/j.apmt.2023.102001 ↗
65. Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery—A Review of the State of the Art10.1016/S0939-6411(00)00087-4 ↗
66. Solid Lipid Nanoparticles: Production, Characterization and Applications10.1016/j.addr.2012.09.021 ↗
67. Solid Lipid Nanoparticles: A Review
68. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review of the Methods of Manufacture and Routes of Administration10.1080/10837450.2022.2084554 ↗
69. Solid Lipid Nanoparticles-A Review
70. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) in Cosmetic and Dermatological Preparations10.1016/S0169-409X(02)00118-7 ↗
71. Lipid Nanoparticles in Topical Dermal Drug Delivery: Does Chemistry of Lipid Persuade Skin Penetration?10.1016/j.jddst.2022.103176 ↗
72. Formulations Based on Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for Cutaneous Use: A Review10.1016/j.ejps.2017.11.023 ↗
73. Viegas, C., Patrício, A.B., Prata, J.M., Nadhman, A., Chintamaneni, P.K., and Fonte, P. (2023). Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics, 15.10.3390/pharmaceutics15061593 ↗
74. Beyond the Adverse Effects of the Systemic Route: Exploiting Nanocarriers for the Topical Treatment of Skin Cancers10.1016/j.addr.2024.115197 ↗
75. Ngokwe, Z.B. (2026). Nanotechnology-Based Approaches in Skin Cancer and Its Treatment. Nanodermatology, Advances in Theory and Practice, Elsevier.
76. Vesicular Systems for Dermal and Transdermal Drug Delivery10.1039/D0RA09561C ↗
77. Lipid Vesicles: A Versatile Drug Delivery Platform for Dermal and Transdermal Applications10.1016/j.colsurfb.2020.111262 ↗
78. Vesicular Drug Delivery Systems: A Breakthrough in Wound Healing Therapies10.1016/j.colsurfb.2025.115046 ↗
79. Skin Drug Delivery Using Lipid Vesicles: A Starting Guideline for Their Development10.1016/j.jconrel.2023.02.006 ↗
80. Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes10.3109/08982109409037057 ↗
81. Structure of the Skin Barrier and Its Modulation by Vesicular Formulations10.1016/S0163-7827(02)00028-0 ↗
82. Skin Structure and Mode of Action of Vesicles10.1016/S0169-409X(02)00114-X ↗
83. Vesicles as a Tool for Transdermal and Dermal Delivery10.1016/j.ddtec.2005.05.003 ↗
84. Lipid Nanocarriers as Skin Drug Delivery Systems: Properties, Mechanisms of Skin Interactions and Medical Applications10.1016/j.ijpharm.2017.10.046 ↗
85. Lipid Vesicles and Other Colloids as Drug Carriers on the Skin10.1016/j.addr.2003.10.028 ↗
86. Lipid-Based Nanoparticles as a Promising Treatment for the Skin Cancer10.1016/j.heliyon.2024.e29898 ↗
87. Nano Vesicular Approaches for the Treatment of Skin Cancer10.1016/j.ijpharm.2025.126265 ↗
88. Recent Advances in the Clinical Application of Transferosomes for Skin Cancer Management10.1016/j.colsurfb.2025.114877 ↗
89. Alex, M., Alsawaftah, N.M., and Husseini, G.A. (2024). State-of-All-the-Art and Prospective Hydrogel-Based Transdermal Drug Delivery Systems. Appl. Sci., 14.10.3390/app14072926 ↗
90. Almoshari, Y. (2022). Novel Hydrogels for Topical Applications: An Updated Comprehensive Review Based on Source. Gels, 8.10.3390/gels8030174 ↗
91. Recent Advances in Hydrogel Based Drug Delivery Systems for the Human Body10.1039/C3TB21016B ↗
92. Biomedical Applications of Functional Hydrogels: Innovative Developments, Relevant Clinical Trials and Advanced Products10.1016/j.biomaterials.2024.122718 ↗
93. An Overview of Hydrogels and Their Role in Transdermal Drug Delivery10.1080/00914037.2020.1740989 ↗
94. Fabrication of Physical and Chemical Crosslinked Hydrogels for Bone Tissue Engineering
95. Hydrogels and Hydrogel-Based Drug Delivery Systems for Promoting Refractory Wound Healing: Applications and Prospects10.1016/j.ijbiomac.2024.138098 ↗
96. Slavkova, M., Tzankov, B., Popova, T., and Voycheva, C. (2023). Gel Formulations for Topical Treatment of Skin Cancer: A Review. Gels, 9.10.3390/gels9050352 ↗
97. Recent Advances in Hydrogel-Based Drug Delivery for Melanoma Cancer Therapy: A Mini Review10.1155/2017/7275985 ↗
98. Microneedles for Transdermal Drug Delivery10.1016/j.addr.2003.10.023 ↗
99. Transdermal Microneedles—A Materials Perspective10.1208/s12249-019-1560-3 ↗
100. Microneedle and Drug Delivery across the Skin: An Overview